Amerigo Allegretto[email protected]UltrasoundUltraCon: Microflow imaging on par with CEUS for guiding tumor ablationMicroflow imaging performs just as well as contrast-enhanced ultrasound (CEUS) for guiding tumor ablation and may be an economic alternative.April 9, 2024UltrasoundUltraCon: Can standardized training improve eFAST learning?A standardized training curricula can be well-received by emergency faculty who are learning extended focused assessment with sonography in trauma (eFAST).April 8, 2024UltrasoundUltraCon: How reliable is POCUS for pancreatic imaging?Point-of-care ultrasound (POCUS) isn’t typically used for imaging the pancreas, but perhaps that should change.April 7, 2024UltrasoundUltraCon: Hands-on training promotes student confidence in ultrasoundHands-on training that works better with medical students' schedules can improve practical skills and foster mentorship for promoting ultrasound use, according to a presentation at UltraCon 2024 in Austin, TX.April 7, 2024UltrasoundAIUM president-elect previews UltraCon 2024AIUM president-elect David Jones, MD, previewed UltraCon 2024 with AuntMinnie.com.April 4, 2024UltrasoundUltrasound shows ties between uterine fibroid risk, family historyUltrasound data shows that family history of uterine fibroids is a risk factor for incident fibroids in Black and African American women.April 3, 2024UltrasoundMicrowave ablation on par with surgery for thyroid cancer survivalMicrowave ablation may be a suitable alternative to surgical resection when it comes to ultrasound-detected thyroid cancer.April 2, 2024Womens ImagingSBI president previews annual symposiumMimi Newell, MD, president of the Society of Breast Imaging (SBI), spoke with AuntMinnie.com about the upcoming SBI annual symposium.April 2, 2024CTIs CTA overused in the emergency department?CT angiography (CTA) may be overused in the emergency department, new research suggests.April 1, 2024Womens ImagingAI shows promise in detecting interval breast cancersAI can detect interval breast cancers that may often be overlooked.April 1, 2024Previous PagePage 33 of 58Next PageTop StoriesRadiation Oncology/TherapyASTRO: Lu-177 PNT2002 added to SBRT delays prostate cancer progressionTwo cycles of lutetium-177 PNT2002 before stereotactic body radiation therapy (SBRT) significantly improved progression-free survival.Radiation Oncology/TherapyASTRO: Contemporary IMRT comparable to proton therapy for throat cancerPractice ManagementNAPT survey results show promise for proton therapyRadiation Oncology/TherapyASTRO: Low-dose RT effective for treating knee osteoarthritisSponsor ContentDigital Innovations Shaping the Future of Radiology